New study aims to improve fluid removal in heart failure patients
NCT ID NCT07593612
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests three different ways to remove excess fluid in people with worsening heart failure. Participants will receive intravenous furosemide alone, or combined with either acetazolamide or hydrochlorothiazide. The goal is to see which combination works best and is safest for outpatient treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE HEART FAILURE (AHF) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Healthy volunteers test two versions of a promising heart failure drug
- Could a heart pill boost exercise capacity in chronic heart failure?
- Nurse coaching may help heart failure patients avoid hospital visits by mastering fluid control
- Sweat-Powered relief: could a High-Tech suit drain fluid from heart failure patients?
- Ultrasound could spot hidden fluid that sends heart patients back to hospital
- Heart scan may predict who benefits from pacemaker therapy